| Literature DB >> 28191276 |
Abstract
Despite evidences of association between basic redox biology and metabolic syndrome (MetS), few studies have evaluated indices that account for multiple oxidative effectors for MetS. Oxidative balance score (OBS) has indicated the role of oxidative stress in chronic disease pathophysiology. In this study, we evaluated OBS as an oxidative balance indicator for estimating risk of MetS with 6414 study participants. OBS is a multiple exogenous factor score for development of disease; therefore, we investigated interplay between oxidative balance and genetic variation for development of MetS focusing on biological pathways by using gene-set-enrichment analysis. As a result, participants in the highest quartile of OBS were less likely to be at risk for MetS than those in the lowest quartile. In addition, persons in the highest quartile of OBS had the lowest level of inflammatory markers including C-reactive protein and WBC. With GWAS-based pathway analysis, we found that VEGF signaling pathway, glutathione metabolism, and Rac-1 pathway were significantly enriched biological pathways involved with OBS on MetS. These findings suggested that mechanism of angiogenesis, oxidative stress, and inflammation can be involved in interaction between OBS and genetic variation on risk of MetS.Entities:
Mesh:
Year: 2017 PMID: 28191276 PMCID: PMC5278231 DOI: 10.1155/2017/6873197
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Baseline characteristics of this study by OBS quantilea.
| Characteristics | Q1 ( | Q2 ( | Q3 ( | Q4 ( |
|
|---|---|---|---|---|---|
| Age (years)a | 57.26 ± 9.00 | 56.62 ± 8.84 | 55.24 ± 8.60 | 54.30 ± 8.27 | <0.001 |
| Sex | <0.001 | ||||
| Male | 1432 (69) | 569 (49) | 817 (37) | 199 (22) | |
| Female | 637 (31) | 600 (51) | 1378 (63) | 711 (78) | |
| Region | <0.001 | ||||
| Rural (Ansung) | 1194 (58) | 618 (53) | 989 (45) | 419 (46) | |
| Urban (Ansan) | 875 (42) | 551 (47) | 1206 (55) | 491 (54) | |
| BMI | 24.30 ± 3.12 | 24.58 ± 3.12 | 24.67 ± 2.92 | 24.65 ± 3.05 | 0.105 |
| Education (years) | <0.001 | ||||
| Elementary school or less | 261 (14) | 300 (12) | 98 (9) | 88 (9) | |
| Middle school graduate | 814 (44) | 1122 (46) | 475 (44) | 420 (44) | |
| High school or higher | 770 (42) | 1036 (42) | 503 (47) | 440 (47) | |
| Monthly incomeb | <0.001 | ||||
| <1000 | 724 (40) | 876 (36) | 318 (30) | 259 (27) | |
| 1000–2000 | 422 (23) | 550 (23) | 238 (22) | 200 (21) | |
| ≥2000 | 682 (37) | 450 (41) | 516 (48) | 486 (52) | |
| Total energy intaked (kcal/day) | 1621.12 ± 471.95 | 1678.42 ± 519.85 | 1831.86 ± 589.55 | 2019.24 ± 848.68 | <0.001 |
aEqual weight method; bUS dollar in 2014; cp for linear trend was determined by the general linear model for continuous variables and by χ2 test for categorical variables. dTotal energy intake was calculated using food frequency questionnaires.
Oxidative balance score assignment scheme.
| OBS components | Score assignment schemea |
|---|---|
| Iron | 0 = high (3rd tertile), 1 = medium (2nd tertile), and 2 = low (1st tertile) |
| Vitamin C | 0 = low (1st tertile), 1 = medium (2nd tertile), and 2 = high (3rd tertile) |
| Retinol | 0 = low (1st tertile), 1 = medium (2nd tertile), and 2 = high (3rd tertile) |
| Carotene | 0 = low (1st tertile), 1 = medium (2nd tertile), and 2 = high (3rd tertile) |
| Physical activity (Phy-MET) | 0 = low (1st tertile), 1 = medium (2nd tertile), and 2 = high (3rd tertile) |
| Smoking | 0 = current smoker, 1 = former smoker, and 2 = never smoker |
| Alcohol | 0 = heavy drinker (≥50 g/day), 2 = nonheavy drinker (<50 g/day) |
aLow, medium, and high categories corresponding to baseline tertile values among participants in the KARE cohort.
Individual component level of OBS between non-MetS and MetS groups.
| Characteristics | Non-MetS | MetS |
|---|---|---|
| Nutrients | ||
| Iron, mg/day | 9.74 ± 5.31 | 9.11 ± 4.54 |
| Vitamin C, mg/day | 103.04 ± 66.79 | 94.40 ± 59.82 |
| Retinol, | 62.47 ± 62.16 | 50.98 ± 53.46 |
| Carotene, | 2429.53 ± 2026.43 | 2412.37 ± 2030.09 |
| Alcohol consumption, g/day | 9.70 ± 22.68 | 9.26 ± 24.72 |
| Nonregular drinker | 4575 | 1470 |
| Regular drinkera | 248 | 101 |
| Smoking status, | ||
| Never | 2944 | 1052 |
| Former | 977 | 238 |
| Current | 911 | 285 |
| Physical activity, MET/day | 82.46 ± 21.11 | 81.44 ± 21.36 |
a≥50 g/day of alcohol drinking; MET, metabolic equivalent.
Association of the OBS with metabolic syndrome by weighing methoda.
| OBS | Number of cases (control) | OR (95% CI) |
|
|
|---|---|---|---|---|
| OBS-equal weight (AUC = 0.823) | ||||
| Quantile 1 | 547 (1522) | 1 | <0.01 | |
| Quantile 2 | 314 (855) | 0.94 (0.78–1.15) | 0.56 | |
| Quantile 3 | 510 (1685) | 0.81 (0.68–0.97) | 0.02 | |
| Quantile 4 | 186 (724) | 0.65 (0.51–0.82) | <0.01 | |
| OBS-equal weightb (AUC = 0.823) | ||||
| Quantile 1 | 353 (1351) | 1 | <0.01 | |
| Quantile 2 | 205 (774) | 0.91 (0.72–1.14) | 0.40 | |
| Quantile 3 | 328 (1513) | 0.79 (0.64–0.97) | 0.02 | |
| Quantile 4 | 118 (644) | 0.60 (0.45–0.81) | <0.01 | |
| OBS-beta coefficient (AUC = 0.824) | ||||
| Quantile 1 | 378 (1204) | 1 | <0.01 | |
| Quantile 2 | 397 (1161) | 0.65 (0.52–0.81) | <0.01 | |
| Quantile 3 | 431 (1209) | 0.67 (0.49–0.90) | <0.01 | |
| Quantile 4 | 355 (1212) | 0.56 (0.76–0.41) | <0.01 | |
| OBS-beta coefficientb (AUC = 0.829) | ||||
| Quantile 1 | 239 (1089) | 1 | <0.01 | |
| Quantile 2 | 272 (1047) | 0.66 (0.50–0.87) | <0.01 | |
| Quantile 3 | 376 (1050) | 0.66 (0.47–0.91) | 0.01 | |
| Quantile 4 | 218 (1107) | 0.56 (0.38–0.82) | <0.01 | |
| OBS-PCA (AUC = 0.824) | ||||
| Quantile 1 | 375 (1203) | 1 (reference) | <0.01 | |
| Quantile 2 | 389 (1174) | 0.64 (0.51–0.79) | <0.01 | |
| Quantile 3 | 419 (1189) | 0.68 (0.50–0.92) | 0.01 | |
| Quantile 4 | 372 (1216) | 0.55 (0.40–0.75) | <0.01 | |
| OBS-PCAb (AUC = 0.828) | ||||
| Quantile 1 | 233 (1087) | 1 | <0.01 | |
| Quantile 2 | 251 (1068) | 0.71 (0.55–0.92) | <0.01 | |
| Quantile 3 | 292 (1037) | 0.66 (0.46–0.96) | 0.03 | |
| Quantile 4 | 228 (1098) | 0.62 (0.43–0.91) | 0.01 | |
aAdjusting for age, sex, area, and BMI. bExcluded patients with type 2 diabetes; n = 5363.
Associations of the OBS with metabolic related disorders by OBS quantile.
| Characteristics | Q1 ( | Q2 ( | Q3 ( | Q4 ( |
|
|---|---|---|---|---|---|
| Metabolic syndrome, | 547 (26) | 314 (27) | 510 (23) | 186 (20) | <0.001 |
| Metabolic components, | |||||
| Abdominal obesity | 686 (30) | 416 (36) | 753 (34) | 305 (34) | 0.071 |
| Hypertriglyceridemia | 748 (36) | 382 (33) | 631 (29) | 235 (26) | <0.001 |
| Low HDL cholesterol | 1087 (53) | 667 (57) | 1294 (59) | 539 (59) | 0.005 |
| High blood pressure | 486 (24) | 287 (25) | 432 (20) | 161 (18) | 0.267 |
| High fasting glucose | 465 (23) | 244 (21) | 392 (18) | 131 (14) | 0.163 |
| MetS score | 1.68 ± 1.30 | 1.71 ± 1.28 | 1.60 ± 1.25 | 1.51 ± 1.25 | <0.001 |
| CRP (mg/dL) | 1.66 ± 3.19 | 1.49 ± 2.69 | 1.55 ± 3.93 | 1.35 ± 3.18 | 0.013 |
| WBC (103/ | 6.70 ± 2.04 | 6.35 ± 1.79 | 6.20 ± 1.82 | 5.97 ± 1.71 | <0.001 |
CRP, C-reactive protein; WBC; white blood cell count; p trend was assessed by χ2 test or general linear regression for linear trend.
Association of the OBS with inflammatory markersa.
| OBS | Beta coefficient | 95% CI |
|
| Beta coefficient | 95% CI |
|
|
|---|---|---|---|---|---|---|---|---|
| CRP (mg/dL) | WBC (103/ | |||||||
| Quantile 1 | 0 | (Reference) | <0.01 | 0 | (Reference) | <0.01 | ||
| Quantile 2 | −0.22 | −0.30 to −0.14 | <0.01 | −0.77 | −0.92 to −0.63 | <0.01 | ||
| Quantile 3 | −0.12 | −0.23 to −0.01 | 0.04 | −0.82 | −1.02 to −0.61 | <0.01 | ||
| Quantile 4 | −0.28 | −0.40 to −0.17 | <0.01 | −0.98 | −1.19 to −0.77 | <0.01 | ||
aAdjusting for age, sex, geographic area, and BMI.
Pathway-based analysis for interaction between OBS and genetic variation for metabolic syndrome.
| Resources | Biological process | Description |
| FDR | Significant genes/selected genes/all genes |
|---|---|---|---|---|---|
| KEGG | VEGF signaling pathway | Genes involved in VEGF signaling pathway. | <0.001 | 0.020 | 25/54/70 |
| KEGG | Glutathione metabolism | Genes involved in glutathione metabolism | <0.001 | 0.022 | 12/26/39 |
| Biocarta | Rac-1 pathway | Rac-1 is a Rho family G protein that stimulates formation of actin-dependent structures | <0.001 | 0.045 | 14/20/22 |
| Biocarta | Rho pathway | Rac-1 is a Rho family G protein that stimulates formation of actin-dependent structures such as filopodia and lamellipodia | 0.001 | 0.062 | 14/25/31 |
| Biocarta | TNFR1 pathway | Tumor necrosis factor alpha binds to its receptor TNFR1 and induces caspase-dependent apoptosis | 0.005 | 0.085 | 13/23/29 |